227) We encountered a patient who developed CME during treatment with nab-paclitaxel for metastatic breast cancer. |
PMID:22592399 DOI:10.1007/s12282-012-0373-y |
2015 Breast cancer (Tokyo, Japan) |
* Cystoid macular edema induced by nab-paclitaxel. |
- Cystoid macular edema (CME) is a rare complication of taxane-based chemotherapy. We encountered a patient who developed CME during treatment with nab-paclitaxel for metastatic breast cancer. Early detection of this disease enables continuation of appropriate treatment without reducing the quality of life for patients with end-stage disease. Physicians should be aware of this potential adverse effect, and should make changes to the treatment of patients as soon as possible. |
(1)62 were | (15)5 participated | (29)2 Basic | (43)2 read |
(2)53 had | (16)5 sexually | (30)2 believed | (44)2 require |
(3)25 are | (17)4 do | (31)2 can | (45)2 required |
(4)25 have | (18)4 is | (32)2 commuted | (46)2 scored |
(5)25 underwent | (19)4 responded | (33)2 consumed | (47)2 showed |
(6)21 received | (20)4 sought | (34)2 deal | (48)2 smoked |
(7)14 presented | (21)3 attended | (35)2 died | (49)2 struggle |
(8)13 developed | (22)3 has | (36)2 experience | (50)2 suffered |
(9)11 reported | (23)3 in | (37)2 had, | (51)2 sustained |
(10)11 was | (24)3 lived | (38)2 live | (52)2 took |
(11)10 completed | (25)3 may | (39)2 lives | (53)2 use |
(12)10 experienced | (26)3 met | (40)2 measured | (54)2 wanted |
(13)8 did | (27)3 work | (41)2 participate | |
(14)5 inject | (28)3 would | (42)2 present |
add keyword